Integra Lifesciences Holdings Corp
- Last sale
- Nov 12, 2026 · -2.81%
- Market cap
- $1.12B
- 77.8M shares
- Filings
- 1,035
Q3 2026+1.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−4.6% FY25 yoy
- $1.12B
- 85.8×
- 0.7×
- 1.0×
- 7.68%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,635,245,000 | reported | |
| FY 2024 | 2024-12-31 | $1,610,527,000 | reported | |
| FY 2023 | 2023-12-31 | $1,541,573,000 | reported | |
| FY 2022 | 2022-12-31 | $1,557,666,000 | reported | |
| FY 2021 | 2021-12-31 | $1,542,448,000 | reported | |
| FY 2020 | 2020-12-31 | $1,371,868,000 | reported | |
| FY 2019 | 2019-12-31 | $1,517,557,000 | reported | |
| FY 2018 | 2018-12-31 | $1,472,441,000 | reported | |
| FY 2017 | 2017-12-31 | $1,188,236,000 | reported | |
| FY 2016 | 2016-12-31 | $992,075,000 | reported | |
| FY 2015 | 2015-12-31 | $882,734,000 | reported | |
| FY 2014 | 2014-12-31 | $796,717,000 revised | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $221.00K | $221.00K | — | 77.94M sh | +0.9% | — |
| FY2024 | — | $52.47M | $52.47M | — | 77.22M sh | −1.3% | 210.2% |
| FY2023 | — | $275.00M | $275.00M | — | 78.22M sh | −4.2% | 376.2% |
| FY2022 | — | $125.00M | $125.00M | — | 81.64M sh | −1.9% | 56.3% |
| FY2021 | — | $0.00 | $0.00 | — | 83.24M sh | −1.3% | 0.0% |
Segments
LineFY2025ShareChange
Codman Specialty Surgical$1.20B73%+5.0%
Tissue Technologies$434.73M27%−6.9%
Orthopedics and Tissue Technologies———
Total$1.64B
Surgical & medical instruments & apparatus
Integra Lifesciences Holdings Corp is the 16th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
PODDInsulet Corp$2.7B30.7%9.1%$10.4BICUIICU Medical Inc$2.2B6.3%0.0%$4.4BTFXTeleflex Inc$2.0B17.2%45.4%$6.1B
IARTIntegra Lifesciences Holdings Corp (this company)$1.6B1.5%31.6%$1.1B
MMSIMerit Medical Systems Inc$1.5B11.8%8.5%$5.2BPENPenumbra Inc$1.4B17.5%12.7%$12.6BHAEHaemonetics Corp$1.3B2.0%7.3%$5.6BEMBCEmbecta Corp.$1.1B3.8%8.8%$364.0MTNDMTandem Diabetes Care Inc$1.0B7.9%20.2%$1.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR